EUVIMEDEUVIMED entdecken
Crossref

Association of genetically proxied cholesteryl ester transfer protein inhibition with risk of intracranial aneurysms: a Mendelian randomization study

Xialong Gu, Xuebin Wen, Lei Ma, Dongfeng Wang, Zhenqiang Li, Maosong Chen, Gengfan Ye

Neurosurgical Review · 28.07.2026 · 49 (1)

DOI: 10.1007/s10143-026-04420-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurosurgical Review, online erschienen am 28.07.2026. Verfasst von Xialong Gu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo 315040, Zhejiang, China. Hauptthemen laut MEDLINE: Cholesterol Ester Transfer Proteins, Intracranial Aneurysm. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Ningbo Medical Science and Technology Project, Ningbo Natural Science Foundation, the Project of Science and technology on Medicine and Health in Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lipid-lowering drugs have been implicated in aneurysm pathophysiology, but whether genetically proxied Cholesteryl Ester Transfer Protein (CETP) inhibition is associated with intracranial aneurysms (IA) and their clinical subtypes remains unclear. This study used drug-target Mendelian randomization to investigate the potential association between genetically proxied CETP inhibition and the risks of IA, subarachnoid hemorrhage (SAH), and unruptured IA (UIA).

Methods

We performed Mendelian randomization (MR) analyses to evaluate the associations of CETP inhibition with risks for IA, SAH and UIA.

Results

SMR analyses provided suggestive evidence that lower CETP expression in whole blood was associated with lower risks of IA (odds ratio [OR] = 0.715, 95% confidence interval [CI] = 0.520–0.984; PSMR = 3.95E-02; PHEIDI = 0.229) and SAH (OR = 0.655, 95% CI = 0.454–0.945; PSMR = 2.36E-02; PHEIDI = 0.459). IVW-MR analyses also yielded suggestive associations for IA (OR = 0.645, 95% CI = 0.440–0.945; p = 0.025) and SAH (OR = 0.643, 95% CI = 0.437–0.946; p = 0.025), which were directionally consistent with the SMR estimates. No association was observed for UIA. After multiplicity correction across the three aneurysm outcomes (Bonferroni-corrected threshold p < 0.017 or Benjamini-Hochberg FDR), the associations remained nominal rather than stringent and should therefore be interpreted as suggestive.

Conclusion

This study provides suggestive genetic evidence consistent with a potential protective association of CETP inhibition with IA rupture and subsequent SAH. Given the borderline statistical significance and the translational limitations of MR-derived estimates, these findings should be regarded as hypothesis-generating and require validation in dedicated pharmacoepidemiological or clinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholesterol Ester Transfer ProteinsIntracranial AneurysmHumansMendelian Randomization AnalysisSubarachnoid HemorrhageGenetic Predisposition to Disease

Stichwörter der Autor:innen

CETP inhibitorsMendelian randomizationintracranial aneurysmssubarachnoid hemorrhage

Substanzen

Cholesterol Ester Transfer ProteinsCETP protein, human

Autor:innen und Institutionen

  • Department of Neurosurgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo 315040, Zhejiang, China.
  • Department of Anesthesiology, The Affiliated Lihuili Hospital of Ningbo University, Ningbo 315040, Zhejiang, China.
  • Department of Neurosurgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo 315040, Zhejiang, China. lhlyegengfan@nbu.edu.cn.

Förderung

  • Ningbo Medical Science and Technology Project
  • Ningbo Natural Science Foundation
  • the Project of Science and technology on Medicine and Health in Zhejiang Province
  • Doctoral Development Foundation of Lihuili Hospital
  • the Opening Foundation of State Key Laboratory of Neurology and Oncology Drug Development

Zitieren

APA

Gu, X., Wen, X., Ma, L., Wang, D., Li, Z., Chen, M., & Ye, G. (2026). Association of genetically proxied cholesteryl ester transfer protein inhibition with risk of intracranial aneurysms: a Mendelian randomization study. Neurosurgical Review, 49(1). https://doi.org/10.1007/s10143-026-04420-9

Vancouver

Gu X, Wen X, Ma L, Wang D, Li Z, Chen M, et al. Association of genetically proxied cholesteryl ester transfer protein inhibition with risk of intracranial aneurysms: a Mendelian randomization study. Neurosurgical Review. 2026;49(1). doi:10.1007/s10143-026-04420-9

BibTeX
@article{Gu2026,
  author = {Gu, Xialong and Wen, Xuebin and Ma, Lei and Wang, Dongfeng and Li, Zhenqiang and Chen, Maosong and Ye, Gengfan},
  title = {Association of genetically proxied cholesteryl ester transfer protein inhibition with risk of intracranial aneurysms: a Mendelian randomization study},
  journal = {Neurosurgical Review},
  year = {2026},
  volume = {49},
  number = {1},
  doi = {10.1007/s10143-026-04420-9}
}
Kostenlos starten →